A University of Michigan-led study is giving new hope to people newly diagnosed with pulmonary arterial hypertension (PAH), a serious condition affecting the heart and lungs. Led by Dr. Vallerie McLaughlin of Michigan Medicine, the research points to a treatment approach that could help patients live longer, healthier lives. Learn how this breakthrough could change the future of PAH care.